Yoshiro Musha

Cervical myelopathy accompanied with hypoplasia of the posterior arch of the atlas: case report.

Study Design Case reports of 2 patients having cervical myelopathy accompanied with idiopathic hypoplasia of the posterior arch of the atlas. Objective A standard for the sagittal inside diameter (SID) of the vertebral foramen of the atlas was determined for use in the diagnosis of hypoplasia. From the point of view of short SID, the etiologies of myelopathy in patients with this disease were analyzed. Summary of Background Data There is no established definition of hypoplasia of the atlantal vertebral foramen. The mechanism underlying the occurrence of this myelopathy in adulthood is unknown. Methods Lateral x-ray views of the cervical vertebrae of 150 Japanese men and 150 Japanese women were investigated, and the standard values of the SID were obtained. The features of myelopathy associated with this disease were analyzed in 2 cases managed at our facility and in the literature. Results The mean standard value was 34.4 mm in women and 37.1 mm in men, showing a significant sex difference (P<0.0001). When a case with a value −2 SD below the standard was regarded as having hypoplasia, case 1 (female) showed 25 mm, that is, −3.9 SD, and case 2 (male) showed 30 mm, that is, −2.7 SD. The space available for the spinal cord of the atlas was 8.0 mm in case 1 and 9.5 mm in case 2. Both patients showed atlantoaxial subluxation on images, but atlantodental interval on flexion in cases 1 and 2 was 3.8 and 4.5 mm, respectively, showing the degree to be mild. Conclusions In the presence of congenital hypoplasia of the posterior arch of the atlas, the spinal cord is highly susceptible to injury because congenital spinal canal stenosis is present. Therefore, the presence of even a mild mechanical compressive lesion leads to myelopathy. Acquired mild atlantoaxial subluxation was associated with this hypoplasia, and the association was considered to be the mechanism underlying the occurrence of myelopathy in adulthood.

Effects of blood on bone cement made of calcium phosphate: Problems and advantages

In recent years, calcium phosphate cements (CPCs) have frequently been used as bone substitutes in the field of orthopedic surgery. When CPC is used as a bone substitute in vivo, blood contamination is unavoidable. To date, however, no detailed study has been conducted focusing on how the physical properties of CPCs would change under the influence of blood. In this study, the effects of blood contamination on Biopex-R (BPR, PENTAX, Tokyo) are examined in vitro and in vivo. The compressive strength of BPR after setting decreased depending on the amount of contaminating blood. The BPR, which has set in vivo, not only has a fragile surface due to the contamination by blood, but also has a propensity to shorten and be destroyed during the early postoperative stage, especially in the bone exposed to loads. On the other hand, radiographic and histological features in vivo indicated that the absorption and the bone replacement of BPR were stimulated by blood contamination. In the clinical evaluation, the patients own peripheral venous blood was added to the BPR. One year after the surgery, the absorption was noted around the hardened BPR. To advance CPCs (including BPR) as bioabsorbable bone replaceable materials, it is essential to utilize the patients own blood in combination with the CPC.

Low Level Laser Therapy for chronic knee joint pain patients

BACKGROUND AND AIMS Chronic knee joint pain is one of the most frequent complaints which is seen in the outpatient clinic in our medical institute. In previous studies we have reported the benefits of low level laser therapy (LLLT) for chronic pain in the shoulder joints, elbow, hand, finger and the lower back. The present study is a report on the effects of LLLT for chronic knee joint pain. MATERIALS AND METHODS Over the past 5 years, 35 subjects visited the outpatient clinic with complaints of chronic knee joint pain caused by the knee osteoarthritis-induced degenerative meniscal tear. They received low level laser therapy. A 1000 mW semi-conductor laser device was used to deliver 20.1 J/cm(2) per point in continuous wave at 830nm, and four points were irradiated per session (1 treatment) twice a week for 4 weeks. RESULTS A visual analogue scale (VAS) was used to determine the effects of LLLT for the chronic pain and after the end of the treatment regimen a significant improvement was observed (p<0.001). After treatment, no significant differences were observed in the knee joint range of motion. Discussions with the patients revealed that it was important for them to learn how to avoid postures that would cause them knee pain in everyday life in order to have continuous benefits from the treatment. CONCLUSION The present study demonstrated that 830 nm LLLT was an effective form of treatment for chronic knee pain caused by knee osteoarthritis. Patients were advised to undertake training involving gentle flexion and extension of the knee.

Weekly Injection of Teriparatide for Bone Ingrowth after Cementless Total Knee Arthroplasty

Purpose. To compare bone mineral density (BMD) in patients with or without weekly injection of teriparatide to promote bone ingrowth after cementless total knee arthroplasty (TKA). Methods. Records of 8 men and 32 women (mean age, 75.6 years) who underwent cementless TKA for medial knee osteoarthritis with (n=20) or without (n=20) once-weekly subcutaneous/hypodermic injection of teriparatide for 48 weeks were reviewed. BMD and bone volume/total volume (BV/TV) of the bone-prosthesis interface of the proximal tibia in 6 regions of interest (ROI) were assessed at 3, 6, 9, and 12 months using multi-detector computed tomography. Results. Patients with or without weekly injection of teriparatide after cementless TKA were comparable in terms of baseline characteristics and pre- and postoperative knee range of motion and Knee Society knee and function scores. In ROI 1 (medial), ROI 3 (anteromedial), and ROI 4 (posteromedial), the BV/TV increased throughout the postoperative period in patients with weekly injection of teriparatide and declined after 6 months in patients without weekly injection of teriparatide. These 3 ROIs of the 2 groups differed significantly only in BMD at 6, 9, and 12 months. In ROI 2 (lateral), ROI 5 (anterolateral), and ROI 6 (posterolateral), both BV/TV and BMD showed a decreasing trend, and these 3 ROIs of the 2 groups did not differ significantly. Conclusion. Weekly injection of teriparatide after cementless TKA promoted bone ingrowth mostly in the medial aspect of the bone-prosthesis interface.

A Diagnostic Scoring System for Sacroiliac Joint Pain Originating from the Posterior Ligament

Objective. Sacroiliac joint (SIJ) pain originating from the posterior ligament manifests in not only the buttocks but also the groin and lower extremities and thus may be difficult to discern from pain secondary to other lumbar disorders. We aimed to develop a simple clinical diagnostic tool to help physicians distinguish between patients with SIJ pain originating from the posterior ligament and those with lumbar disc herniation (LDH) or lumbar spinal canal stenosis (LSS). Design. Prospective case-control study. Patients and Methods. We evaluated 62 patients with SIJ pain originating from the posterior ligament and 59 patients with LDH and LSS. Pain areas, pain increasing positions, provocation test, and tenderness points were investigated. A scoring system based on multivariate logistic regression equations using the investigated items was developed. Results. Two pain areas (the posterosuperior iliac spine (PSIS) detected by the one-finger test and groin), pain while sitting on a chair, provocation test, and two tenderness points (PSIS and the sacrotuberous ligament) had high odds ratios (range, 25.87–1.40) and were used as factors in the scoring system. An integer score derived from the regression coefficient and clinical experience was assigned to each identified risk factor. The sum of the risk score for each patient ranged from 0–9. This scoring system had a sensitivity of 90.3% and a specificity of 86.4% for a positivity cutoff point of 4. Conclusion. The scoring system can help distinguish between patients with SIJ pain originating from the posterior ligament and those with LDH and LSS.

Fabrication of Novel Hemostatic Film with Oxidized Cellulose and Sugar-Containing Hydroxyapatite

The novel hemostatic film for the surgery of bone diseases was fabricated using TEMPO(2,2,6,6-tetramethylpiperidine-1-oxyl)-oxidized cellulose nanofibers (TOCNs), and phosphoryl oligosaccharides of calcium (POs-Ca) or sugar-containing hydroxyapatite (s-Ca10(PO4)6(OH)2; s-HAp). Three kinds of the hydrophilic and transparent films with the thicknesses of 10 to 20 μm were fabricated, i.e., TOCN, POs-Ca-added TOCN and s-HAp-added TOCN films. Among these films, the uptake amount of the simulated body fluid by s-HAp-added TOCN film was as high as 5,543%, which was expected to quickly stop bleeding of larger amount of blood for the hemostasis.

Elevation of fibrin degradation product (FDP) values prevents the negative conversion of serum CRP values after total knee arthroplasty

Background It is essential as an orthopedic surgeon to diagnose prosthetic joint infection (PJI) at an early stage and to carry out precise treatment as well as preventing the deterioration of functional prognosis as much as possible. We suspected that PJI might have been caused because the negative conversion of creatinine reactive protein (CRP) has been prolonged after total knee arthroplasty (TKA) and patients with no serum CRP negative conversion have been treated with antibiotics to avoid the morbidity of PJI. The purpose of the present study is to investigate the factors associated with prolongation of the negative conversion of CRP, with the exclusion of PJI patients. Methods We performed a retrospective case control study at our institution from August 2014 to August 2016. We classified the patients into two groups based on whether it required ≥20 days (Group A, n = 23) or <20 days (Group B, n = 23) for CRP levels to normalize. Serum D-Dimer and fibrin degradation product (FDP) values were measured at 1, 2, 5, 9, 12, 16, 19, 23, 26, and 30 days after TKA. Exclusion criteria include anticoagulant oral administration cases before TKA, venous thromboembolism (VTE) by postoperative lower limb venous echocardiography before and after TKA, CRP re-elevation cases, and patients with PJI. The cutoff points for D-dimer and FDP levels for screening tests were calculated from the receiver operating characteristic (ROC) curve. Results The ROC analysis of D- Dimer values at 30 days after TKA yielded an AUC of 0.891 (95% confidence interval (CI) 0.858-1.000), which indicates nearly an excellent test. The cutoff point of 22.1 μg/dl for FDP value (Younden Index: 22.1 μg/dl) showed a sensitivity of 81.8% (95% CI 70.1-92.8) and a specificity of 80.0% (95% CI 67.9-89.1). Conclusion We revealed that CRP values of patient with an FDP level ≥22.1 μg/dl at 30 days after TKA necessarily showed negative conversion without antibiotic administration, when examining a patient with elevated serum CRP of minor criteria in the definition of PJI proposed by MSIS (other criteria do not apply). Level of evidence Ⅲ.

Use of porous monoblock patella component should avoid for patient with patella baja

Background Although many studies have evaluated the success of porous tantalum component in primary and revision cementless total knee arthroplasty (TKA) cases, few studies have reported the breakage of porous tantalum monoblock patella component (PTMP). The purpose of this study was to investigate the radiographic outcomes of breakage of PTMP at short-term follow up. Methods This was a retrospective study of 49 consecutive knees in 43 patients who underwent TKA surgery between September 2012 and March 2014. Bone marrow contents/tissue volumes (BMC/TV. mg/cm3) were evaluated using 2-dimensional osteomorphometry software with 2D- multi-detector-row computed tomography (2D-MDCT) to measure fixation of the bone-prosthesis interface with patella at 6, 12, and 24 months after surgery. Clinical follow up was obtained by reviewing each patient at orthopedic record. Results We experienced a case that resulted in breakage of PTMP without traumatic episode at 26 months after surgery. Relative changes of Bone Mineral Contents per Tissue Volume. (BMC/TV mg/cm3) at ROI. 1 (superior border of the patella) and ROI. 2 (peg of patella) were significantly higher than ROI.3 (inferior border of patella) at 6, 12 and 24 months after surgery (p < 0.001. p < 0.01). Patient with breakage of PTMP has patella baja (Insall- Salvati ratio: 0.72), and the relative change of BMC/TV at ROI.1 and 2 for patients who experienced a breakage of PTMP was higher than any other patients. Conclusion The present study revealed that the use of PTMP should be avoided for patients with patella baja.

Contiguous sagittal split fractures of cervical vertebrae bodies with no neurological impairment

A high percentage of sagittal fractures of cervical vertebrae bodies occur as teardrop, compression, and other types of fractures, or as dislocations, and are frequently accompanied by spinal-cord injuries [1–11]. These cases are frequently seen in level 1 trauma centers. However, the case of isolated sagittal fracture, in which no other kinds of fractures or dislocations occur within the same and/or the neighboring vertebral bodies, is rare [12–14]. We examined how such injuries occur by studying one case of multiple contiguous isolated sagittal fractures with no neurological deficit. The relationship between the mechanism of trauma and spinal-cord damage was also examined. The patient was informed that data concerning the case would be submitted for publication, and he consented. Case report

Properties of novel bone hemostat prepared using sugar-modified hydroxyapatite, phosphoryl oligosaccharides of calcium and thermoplastic resin

A novel hemostatic agent was prepared using phosphoryl oligosaccharides of calcium (POs-Ca), hydroxyapatite (Ca10(PO4)6(OH)2; HAp) obtained by the hydrolysis of POs-Ca or sugar-containing HAp (s-HAp; 60.3 mass% calcium-deficient HAp and 39.5 mass% organic materials, Ca/P ratio = 1.56) and thermoplastic resin (the mixture of random copolymer of ethylene oxide/propylene oxide (EPO) and polyethylene oxide (EO); EPO : EO : water = 25 : 15 : 60 (mass ratio); 25EPO-15EO). The gel formed by mixing 25EPO-15EO with water (25EPO-15EO/water mass ratio: 0.20) was flash frozen at -80°C, freeze-dried at -50°C for 15 h and then ground using mixer. The consistency conditions of hemostats mixed with POs-Ca or s-HAp were optimized for the practical uses. The mean stanching times of hemostats were: s-HAp/25EPO-15EO (8.2 h; s-HAp/25EPO-15EO = 0.20) > 25EPO-15EO (5.3 h) > POs-Ca/25EPO-15EO (4.7 h; POs-Ca/25EPO-15EO = 0.20). The gentamicin, a typical antibiotic agent, loaded s-HAp/25EPO-15EO composite hemostat showed the steady state releasing in phosphate buffered saline till 10 h immersion at 37.0°C.